Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

8 results
  1. ... FOLFOX with or without bevacizumab, but this trial closed because of poor accrual; ... that combined oxaliplatin with fluoropyrimidine-based chemoradiation therapy ...
  2. ... 5 Gy/30 fractions for T2).[ 10 ] The study was underpowered and closed early because of a lack of accrual, although no statistically significant differences were seen between treatment arms in terms of local progression-free survival ( ...
  3. ... P = .13). The European Organization for Research and ... study closed because of poor accrual, and a combined analysis of the study and ...
  4. ... reach agreement on proposed changes to increase patient accrual and dose , ... as a clinical therapy against several different types of cancer, alone or ...
  5. ... asymptomatic men who were considered unsuitable for curative treatment because of age, comorbidity, or locally advanced disease (11% of the study population). Planned accrual was 750 patients, but because of slow accrual, the trial closed at 293 patients. In groups 1 and 2 ...
  6. ... radiation followed by gemcitabine.[ 17 ] Of note, the study was closed early as ... for combined modality therapy (one-sided P = .017 by stratified log-rank ...
  7. ... 0.41–0.58; P < .00001). In this study, the number needed to treat with radiation ... closed because of poor accrual (636 of planned 1,790 patients accrued). Patients ...
  8. ... treatment(s) in order to establish comparative effectiveness studies between multiple treatments. A greater emphasis on baseline covariate data may ... care can significantly impact the design of a study as new treatments are approved or new patient populations become of ...